Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.275
+0.002 (0.70%)
Nov 21, 2024, 12:39 PM EST - Market open
Aptose Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 20 | 53 | 122 | 390 | 431 | |
| Market Cap Growth | -65.29% | -62.12% | -56.27% | -68.80% | -9.61% | 499.24% | |
| Enterprise Value | 8 | 3 | -3 | 27 | 252 | 402 | |
| Last Close Price | 0.27 | 2.54 | 8.70 | 20.25 | 65.70 | 85.05 | |
| PB Ratio | -0.78 | -6.94 | 1.41 | 1.64 | 3.28 | 4.59 | |
| P/TBV Ratio | - | - | 1.41 | 1.64 | 3.28 | 4.60 | |
| Debt / Equity Ratio | -1.17 | -0.35 | 0.03 | 0.01 | 0.01 | 0.02 | |
| Quick Ratio | 0.82 | 0.61 | 3.82 | 9.68 | 17.97 | 17.62 | |
| Current Ratio | 1.05 | 0.78 | 4.03 | 10.00 | 18.36 | 17.83 | |
| Return on Equity (ROE) | - | -293.96% | -74.70% | -67.67% | -51.91% | -48.66% | |
| Return on Assets (ROA) | -142.26% | -102.23% | -39.87% | -39.18% | -30.74% | -28.61% | |
| Return on Capital (ROIC) | -432.03% | -176.13% | -46.77% | -42.00% | -32.36% | -30.65% | |
| Earnings Yield | -684.89% | -254.17% | -78.63% | -53.73% | -14.17% | -6.09% | |
| FCF Yield | -711.21% | -221.47% | -60.81% | -35.77% | -8.71% | -5.02% | |
| Buyback Yield / Dilution | -121.77% | -9.82% | -3.57% | -8.86% | -63.15% | -50.22% | |
| Total Shareholder Return | -121.77% | -9.82% | -3.57% | -8.86% | -63.15% | -50.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.